Search results

Addex Therapeutics is a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders.

Atopia Therapeutics is developing a revolutionary treatment for allergic diseases such as atopic dermatitis, allergic asthma, food allergies and hay fever based on the discovery that a bacterium present in the human stomach produces a protein that protects us from these diseases.

AzureCell is a Swiss regenerative cell therapy company leveraging two decades of pioneering neuroscience and cell‑engineering research at the University of Geneva to advance next‑generation allogeneic cell‑replacement therapies for the brain.

Calliditas is a commercial stage biopharmaceutical company focused on novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs. In 2021, Calliditas acquired Genkyotex, specializing company in NOX therapies, French & Swiss based.

We want to be strategic collaborator with executive management and empower in-house IR/PR professionals to help you build lasting and mutually beneficial relationships with investors, partners, media, and other stakeholders.

EspeRare is an ethical non-profit biotech. It combines pharmaceutical know-how and philanthropic and public investments to bring to life treatments that have been abandoned by the pharmaceutical industry. EspeRare represents an affordable alternative to the high cost innovation of medicines.

Fasteris is the LifeScience brand of Genesupport SA, that offers DNA-sequencing services to LifeScience companies and research. Genesupport SA offers a complete service in the field of human genetics (prenatal, paediatric and adult), delivered by FMH and FAMH specialists.

HekeTiss, a UNIGE/HUG spin-off, enhances lives by pioneering cell-therapy treatments for ulcerative skin conditions. Innovating for a healthier tomorrow.

Infinity Communications works with start-up and growth-stage healthcare companies to deliver insights-driven, strategic communications. We add value by developing content and material to raise your company profile, attract new investors and engage audience groups across the health ecosystem.

The company helps pharmaceutical and biotech companies to develop new drugs by providing a full range of testing services, from preclinical investigations to conducting post-marketing studies. Services include toxicology studies and biostatistical analysis.

Novimmune SA has brought 7 monoclonal antibodies to clinical development stage, one of which, Emapalumab, has been approved by the FDA in 2018. We now focus on our bispecific technology to build a pipeline of multispecific antibodies under the brand Light Chain Bioscience.

OM Pharma is a global Geneva-based biopharmaceutical company. It is a leader in the prevention of recurrent respiratory and urinary tract infections, also active in the treatment of vascular diseases.

We are a small CRO providing highly tailored services to customers with clinical trials and regulatory consulting needs. With expertise in drug, food supplements, medical devices, diagnostics and software, we support you at every stage of product's lifecycle, from preclinical development to market.

QuartzBio SA is a Swiss data driven biomarker discovery and validation company and the trusted partner of companies and institutions for their in-silico biomarker discovery programmes. Leveraging a unique Biomarker Optimisation Software System – BOSS™ – we discover and validate biomarkers.

Solid Drug Development (SDD) is a Strategic and Operational consultancy based in Geneva. The company founded in 2010 is specialized in the development of Biotech and Pharma products.

TheraPPI Bioscience, a preclinical biotechnology company developing small molecules modifying protein interactions in oncology, rare diseases and inflammation